Darunavir (CED0003103)

Record Information
Version1.0
Creation Date2016-05-22 05:56:42 UTC
Update Date2026-08-22 07:42:45 UTC
Accession NumberCHEM019245
Identification
Common NameDarunavir
ClassSmall Molecule
Description
Darunavir is an organic compound with the chemical formula C27H37N3O7S. Darunavir belongs to the benzenesulfonamides, a subclass of benzene and substituted derivatives within the organic compounds. With an average molecular weight of 547.66 g/mol, Darunavir is a heavy molecule. This compound has been identified in or released from five recorded sources. These include pharmaceuticals and veterinary products, specifically antivirals and gynecologicals, as well as electrical and electronic equipment such as video games and television systems. Additionally, it is found in household cleaning and consumer products, specifically non electric simulated smoking devices. The recorded route of exposure for this substance is oral. In terms of biological activity, Darunavir interacts with two recorded protein targets. It functions as an inhibitor or modulator of the Pol polyprotein and the Gag-Pol polyprotein (gag-pol).
Contaminant Type
  • Human Neurotoxin
Chemical Structure
Synonyms
ValueSource
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamateChEBI
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamATEChEBI
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamateChEBI
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamateChEBI
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterChEBI
DarunavirumChEBI
N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamideChEBI
TMC114ChEBI
{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterChEBI
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamic acidGenerator
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulphanilamido)propyl)carbamateGenerator
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulphanilamido)propyl)carbamic acidGenerator
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamic acidGenerator
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulphonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamateGenerator
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulphonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamic acidGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acidGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamateGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acidGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acidGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamateGenerator
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acidGenerator
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
[(S)-3-[(4-Amino-benzenesulphonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
[(S)-3-[(4-Amino-benzenesulphonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
N-((1S,2R)-3-(((4-Aminophenyl)sulphonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamideGenerator
{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
{(1S,2R)-3-[(4-amino-benzenesulphonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
{(1S,2R)-3-[(4-amino-benzenesulphonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) esterGenerator
AIDS073035HMDB
TMC-114HMDB
UIC-94017HMDB
114, TMCHMDB
TMC 114HMDB
Ethanolate, darunavirHMDB
Darunavir ethanolateHMDB
PrezistaHMDB
Chemical FormulaC27H37N3O7S
Average Molecular Mass547.664 g/mol
Monoisotopic Mass547.235 g/mol
CAS Registry Number206361-99-1
IUPAC Name(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate
Traditional Namedarunavir
SMILES[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
InChI IdentifierInChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1
InChI KeyCJBJHOAVZSMMDJ-HEXNFIEUSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentAminobenzenesulfonamides
Alternative Parents
Substituents
  • Aminobenzenesulfonamide
  • Phenylbutylamine
  • Amphetamine or derivatives
  • Benzenesulfonyl group
  • Furofuran
  • Aniline or substituted anilines
  • Organosulfonic acid amide
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Sulfonyl
  • Tetrahydrofuran
  • Carbamic acid ester
  • Aminosulfonyl compound
  • Secondary alcohol
  • Carbonic acid derivative
  • Oxacycle
  • Organoheterocyclic compound
  • Acetal
  • Hydrocarbon derivative
  • Organic oxide
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Primary amine
  • Organopnictogen compound
  • Carbonyl group
  • Amine
  • Organic nitrogen compound
  • Organic oxygen compound
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.067 g/LALOGPS
logP1.76ALOGPS
logP2.82ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)13.59ChemAxon
pKa (Strongest Basic)2.39ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area140.42 ŲChemAxon
Rotatable Bond Count11ChemAxon
Refractivity142.34 m³·mol⁻¹ChemAxon
Polarizability57.24 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0006-7395120000-9ee6643d8e957bfc6883Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-08i3-8659131000-a5895dfe8fa0c5374f22Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aor-0900800000-e427a102e3a7551cc732Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0900000000-8ab8c2b3421f4a277282Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2900000000-eddacc917eaf16abe9d2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2900000000-86c785caeafe3b4a10c3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-5900000000-69bc90a59383cb5a804bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-8900000000-f481d0932a99692c87d9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000g-0009760000-f730e27547a482694ebcNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0009000000-fcd18a6f4e9084f0f8f1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0469000000-716a2ae87ad9df6765fbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0941000000-5e0dbe51025009642b33Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0910000000-2411514d55bfa3c4e81fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-2309000000-e6767f5d8648334c41c9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9621000000-3a7c794f5e3f473b9ad5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9400000000-16b363cdd836532460ceNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2900000000-98bfa9c688e4cb2dbbc3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-4900000000-05c5a10ff111a5d1c9bfNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052f-6900000000-f59c1c0d97f0a8ab00d7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0900000000-40373637b670c5395ffdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aor-0900800000-f59913cdbcd62042530aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2900000000-10dadadeebe1e6ec0164Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0009000000-8e1cc4b8ca6f49bcfe56Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000g-0009760000-26cdc56a39511d44e965Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-2309000000-b56fe3acae7c21ddaba0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0941000000-5e0dbe51025009642b33Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0469000000-c470e3e505d43b7089afNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0941000000-1bfc191c3ef7c76e399aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0469000000-716a2ae87ad9df6765fbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0469000000-88a2aa3a18e68a6a8c87Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0009000000-cd24e55f9cffee600214Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0910000000-2411514d55bfa3c4e81fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000g-0009760000-3737a6b429e0f4409291Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000g-0009760000-f730e27547a482694ebcNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0931000000-eca02149631677bcfffbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0920000000-6021e5dbfe305dd0d6e8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9400000000-f273ebedf1f30673e27aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0931000000-a21e0c76b0d45400f9a4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9621000000-d2b39c8b2f2aa174b4f1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a59-9401140000-56eac45c2f7be4c47482Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9301000000-bb8cecd1683edef150feNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9100000000-08319e638dc9213da395Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00mk-0805970000-4bf40ac64acd286d67f2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-2933410000-f89d6de3a367503d41e5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-05dl-4933200000-1375ea05a3f120000d76Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ot-1824290000-f54a2a5d6339d60e43dfNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-08fu-2910210000-e350bf727a2edf01f5d6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014l-9100000000-31fd1c1da3df0c11b9f6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0900240000-072c834a66c41bb38b74Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-2902210000-7da1d822e71f91c229c9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-054o-2901000000-d4858cb299ffb926598eNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
649.0Log mg/kg[360:1200]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
316GynecologicalsHealthcare, pharmaceuticals & veterinary productsNot Available
351AntiviralsHealthcare, pharmaceuticals & veterinary productsNot Available
537Television SystemsElectrical & Electronic EquipmentNot Available
539Video GamesElectrical & Electronic EquipmentNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
643HeadwearTextiles, leather & furnishingsNot Available
Pathways
3 pathways
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureProteaseQ9YQ12Human immunodeficiency virus 1Predicted (SEA)0.0778492
Click to view 3D structurePol polyproteinQ72874Human immunodeficiency virus 1Predicted (SEA)0.311397
Gag-Pol polyprotein structureClick to view 3D structureGag-Pol polyproteinP03369HIV-1Predicted (SEA)1.32344
ATP-dependent translocase ABCB1 structureClick to view 3D structureATP-dependent translocase ABCB1P08183HumansPredicted (SEA)18.6838
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)477.216
Click to view 3D structureThromboxane-A synthaseP24557HumansPredicted (SEA)13.8572
Gamma-secretase subunit PEN-2 structureClick to view 3D structureGamma-secretase subunit PEN-2Q9NZ42HumansPredicted (SEA)47.7994
Cytochrome P450 3A5 structureClick to view 3D structureCytochrome P450 3A5P20815HumansPredicted (SEA)1.01204
Stromelysin-1 structureClick to view 3D structureStromelysin-1P08254HumansPredicted (SEA)248.806
72 kDa type IV collagenase structureClick to view 3D structure72 kDa type IV collagenaseP08253HumansPredicted (SEA)416.649
Matrix metalloproteinase-9 structureClick to view 3D structureMatrix metalloproteinase-9P14780HumansPredicted (SEA)379.281
Interstitial collagenase structureClick to view 3D structureInterstitial collagenaseP03956HumansPredicted (SEA)295.126
Renin structureClick to view 3D structureReninP00797HumansPredicted (SEA)153.908
Neutrophil collagenase structureClick to view 3D structureNeutrophil collagenaseP22894HumansPredicted (SEA)306.959
Collagenase 3 structureClick to view 3D structureCollagenase 3P45452HumansPredicted (SEA)345.962
Cathepsin D structureClick to view 3D structureCathepsin DP07339HumansPredicted (SEA)178.353
Click to view 3D structureHuman rhinovirus A proteaseQ4U254Human rhinovirus sp.Predicted (SEA)64.8484
Beta-secretase 1 structureClick to view 3D structureBeta-secretase 1P56817HumansPredicted (SEA)208.169
Replicase polyprotein 1ab structureClick to view 3D structureReplicase polyprotein 1abP0DTD1SARS-CoV-2Predicted (SEA)221.403
Carbonic anhydrase 2 structureClick to view 3D structureCarbonic anhydrase 2P00918HumansPredicted (SEA)665.066
Carbonic anhydrase 1 structureClick to view 3D structureCarbonic anhydrase 1P00915HumansPredicted (SEA)554.364
Click to view 3D structureUDP-glucuronosyltransferase 1A1Q64550Rattus norvegicusPredicted (SEA)22.5763
Matrix metalloproteinase-14 structureClick to view 3D structureMatrix metalloproteinase-14P50281HumansPredicted (SEA)401.235
Disintegrin and metalloproteinase domain-containing protein 17 structureClick to view 3D structureDisintegrin and metalloproteinase domain-containing protein 17P78536HumansPredicted (SEA)273.406
Click to view 3D structureCholinesteraseP81908Equus caballusPredicted (SEA)438.447
Concentrations
Not Available
External Links
DrugBank IDDB01264
HMDB IDHMDB0015393
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB ID017
Wikipedia LinkDarunavir
Chemspider ID184733
ChEBI ID367163
PubChem Compound ID213039
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. De Meyer S, Azijn H, Surleraux D, Jochmans D, Tahri A, Pauwels R, Wigerinck P, de Bethune MP: TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. Antimicrob Agents Chemother. 2005 Jun;49(6):2314-21.
2. Kovalevsky AY, Tie Y, Liu F, Boross PI, Wang YF, Leshchenko S, Ghosh AK, Harrison RW, Weber IT: Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M. J Med Chem. 2006 Feb 23;49(4):1379-87.
3. Koh Y, Matsumi S, Das D, Amano M, Davis DA, Li J, Leschenko S, Baldridge A, Shioda T, Yarchoan R, Ghosh AK, Mitsuya H: Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J Biol Chem. 2007 Sep 28;282(39):28709-20. Epub 2007 Jul 17.
4. Back D, Sekar V, Hoetelmans RM: Darunavir: pharmacokinetics and drug interactions. Antivir Ther. 2008;13(1):1-13.
5. Tremblay CL: Combating HIV resistance - focus on darunavir. Ther Clin Risk Manag. 2008 Aug;4(4):759-66.
6. Company Website: http://www.prezista.com/prezista/qanda_about_prezista.html
7. Medilexicon: http://www.medilexicon.com/drugs/prezista.php
8. https://www.ncbi.nlm.nih.gov/pubmed/?term=15771427
9. https://www.ncbi.nlm.nih.gov/pubmed/?term=16480273
10. https://www.ncbi.nlm.nih.gov/pubmed/?term=25017682